MENU

BIIB Biogen Forecast, Technical & Fundamental Analysis

a manufacturer of therapies for people living with neurological, autoimmune and hematologic disorders

BIIB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
BIIB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

BIIB is expected to report earnings to fall 28.60% to $3.77 per share on October 30

Biogen BIIB Stock Earnings Reports
Q3'24
Est.
$3.77
Q2'24
Beat
by $1.27
Q1'24
Beat
by $0.24
Q4'23
Missed
by $0.23
Q3'23
Beat
by $0.37
The last earnings report on August 01 showed earnings per share of $5.28, beating the estimate of $4.01. With 1.43M shares outstanding, the current market capitalization sits at 31.34B.
A.I. Advisor
published General Information

General Information

a manufacturer of therapies for people living with neurological, autoimmune and hematologic disorders

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Biotechnology
Address
225 Binney Street
Phone
+1 617 679-2000
Employees
7570
Web
https://www.biogen.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME20.910.41
+2.00%
GameStop Corp
SPY576.13-1.01
-0.18%
SPDR® S&P 500® ETF Trust
AAPL229.04-0.50
-0.22%
Apple
BTC.X60274.500000-307.601560
-0.51%
Bitcoin cryptocurrency
TSLA238.77-2.28
-0.95%
Tesla

BIIB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BIIB has been loosely correlated with AMGN. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if BIIB jumps, then AMGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIIB
1D Price
Change %
BIIB100%
+1.52%
AMGN - BIIB
42%
Loosely correlated
-0.43%
OGN - BIIB
36%
Loosely correlated
-0.28%
GILD - BIIB
33%
Loosely correlated
-1.71%
AZN - BIIB
32%
Poorly correlated
-0.82%
NVS - BIIB
29%
Poorly correlated
-0.72%
More